Figure 2.
Standardized Mean Differences in Patient Characteristics Before and After Matching. (A) shows the results for patients diagnosed with COVID-19. (B) shows the results for patients diagnosed with COVID-19 plus suspected COVID-19 patients. Top panel show data for any α1-AR antagonists; bottom panels show data for doxazosin.